- Home
- GALT vs CENX Comparison
GALT vs CENX Comparison
Compare GALT & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- CENX
- Stock Information
- Founded
- GALT 2000
- CENX 1995
- Country
- GALT United States
- CENX United States
- Employees
- GALT N/A
- CENX N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- GALT Health Care
- CENX Industrials
- Exchange
- GALT Nasdaq
- CENX Nasdaq
- Market Cap
- GALT 83.5M
- CENX 1.8B
- IPO Year
- GALT N/A
- CENX 1996
- Fundamental
- Price
- GALT $2.45
- CENX $18.02
- Analyst Decision
- GALT Buy
- CENX Strong Buy
- Analyst Count
- GALT 2
- CENX 3
- Target Price
- GALT $6.00
- CENX $23.00
- AVG Volume (30 Days)
- GALT 1.4M
- CENX 1.8M
- Earning Date
- GALT 08-12-2025
- CENX 08-07-2025
- Dividend Yield
- GALT N/A
- CENX N/A
- EPS Growth
- GALT N/A
- CENX N/A
- EPS
- GALT N/A
- CENX 1.22
- Revenue
- GALT N/A
- CENX $2,364,700,000.00
- Revenue This Year
- GALT N/A
- CENX $7.19
- Revenue Next Year
- GALT N/A
- CENX $3.99
- P/E Ratio
- GALT N/A
- CENX $14.79
- Revenue Growth
- GALT N/A
- CENX 11.41
- 52 Week Low
- GALT $0.73
- CENX $11.40
- 52 Week High
- GALT $3.90
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- GALT 61.39
- CENX 53.93
- Support Level
- GALT $2.21
- CENX $16.90
- Resistance Level
- GALT $3.90
- CENX $17.89
- Average True Range (ATR)
- GALT 0.47
- CENX 0.75
- MACD
- GALT 0.09
- CENX -0.19
- Stochastic Oscillator
- GALT 40.84
- CENX 43.19
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.